G. G. Eskiler Et Al. , "Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer," PHARMACEUTICAL RESEARCH , vol.35, no.11, 2018
Eskiler, G. G. Et Al. 2018. Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer. PHARMACEUTICAL RESEARCH , vol.35, no.11 .
Eskiler, G. G., ÇEÇENER, G., EGELİ, Ü., & TUNCA, B., (2018). Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer. PHARMACEUTICAL RESEARCH , vol.35, no.11.
Eskiler, Gamze Et Al. "Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer," PHARMACEUTICAL RESEARCH , vol.35, no.11, 2018
Eskiler, Gamze G. Et Al. "Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer." PHARMACEUTICAL RESEARCH , vol.35, no.11, 2018
Eskiler, G. G. Et Al. (2018) . "Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer." PHARMACEUTICAL RESEARCH , vol.35, no.11.
@article{article, author={Gamze Guney Eskiler Et Al. }, title={Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer}, journal={PHARMACEUTICAL RESEARCH}, year=2018}